| Literature DB >> 32447488 |
Upendra Kaul1, Saumitra Ray2, D Prabhakar3, Arun Kochar4, Kamal Sharma5, Prakash Kumar Hazra6, Subhash Chandra7, Dharmesh Ramakant Bhai Solanki8, Anjan Lal Dutta9, Viveka Kumar10, M Srinivas Rao11, Abraham Oomman12, Sameer Dani13, Brian Pinto14, T R Raghu15.
Abstract
Type 2 diabetes mellitus (T2DM) is a known predisposing factor for heart failure (HF). The growing burden of these two conditions and their impact on health of the individual and on society in general needs urgent attention from the health care professionals. Availability of multiple treatment choices for managing T2DM and HF may make therapeutic decisions more complex for clinicians. Recent cardiovascular outcome trials of antidiabetic drugs have added very robust evidence to effectively manage subjects with this dual condition. This consensus statement provides the prevalence trends and the impact of this dual burden on patients. In addition, it concisely narrates the types of HF, the different treatment algorithms, and recommendations for physicians to comprehensively manage such patients.Entities:
Keywords: Diagnosis; Drug; Heart failure; Trials; Type 2 diabetes mellitus
Mesh:
Substances:
Year: 2021 PMID: 32447488 DOI: 10.1007/s10741-020-09955-7
Source DB: PubMed Journal: Heart Fail Rev ISSN: 1382-4147 Impact factor: 4.214